Luvida secures £424.5k for clinical trial AI platform

Luvida's AI platform aims to integrate patient intelligence into the clinical trial design process. By providing tools to predict risk and improve recruitment, the technology helps clinical teams prevent protocol amendments before they occur.

The recent funding round of £424.5k values the business at an estimated £6m.

Luvida Ltd (company number 16224669) was incorporated in February 2025 and is headquartered in London, GB. It currently maintains a headcount of six staff members. The business operates within the field of software development, focusing on writing, modifying, testing, and supporting applications for business and domestic use. Its technical scope also includes the design and implementation of systems, databases, and web pages for its clients.

The investment was finalized with an allotment date in June 2026. The company maintains its digital presence at luvida.co.uk.